MYLK2 Inhibitors

Myosin light chain kinases (MYLK, also designated MLCK) phosphorylate myosin regulatory light chains to catalyze myosin interaction with actin filaments resulting in contractile activity. MYLK members are known to include MYLK2, MYLK3 and MYLK4. MYLK2 Inhibitors offered by Santa Cruz inhibit MYLK2 and, in some cases, other serine/threonine and CaM kinase related proteins. View detailed MYLK2 Inhibitor specifications, including MYLK2 Inhibitor CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.

PRODUCT NAME/ApplicationCASCatalog #QUANTITYPriceCitationsRATING
MYLK2 inhibitor
0.5 mg/0.1 ml

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.